Breathe Well Live Well
|
Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge …
Sacramento Bee ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as … |
View full post on asthma – Google News
|
Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge …
PR Newswire (press release) ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as … |
View full post on asthma – Google News
 TopNews Arab Emirates |
FDA Approves Pharmaxis' Asthma Test Kit Aridol
TopNews United Kingdom Pharmaxis' asthma test kit Aridol has been shown green signal by the US Food and Drug Administration for commercialization in US. … US approves Pharmaxis asthma test Pharmaxis (PXS) $2.40: Tim Boreham Pharmaxis gets the right news at the right time |
View full post on asthma – Google News